JP2024534173A5 - - Google Patents
Info
- Publication number
- JP2024534173A5 JP2024534173A5 JP2024513202A JP2024513202A JP2024534173A5 JP 2024534173 A5 JP2024534173 A5 JP 2024534173A5 JP 2024513202 A JP2024513202 A JP 2024513202A JP 2024513202 A JP2024513202 A JP 2024513202A JP 2024534173 A5 JP2024534173 A5 JP 2024534173A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- treatment
- acceptable salt
- mads
- mandibular advancement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163239064P | 2021-08-31 | 2021-08-31 | |
| US63/239,064 | 2021-08-31 | ||
| PCT/US2022/041990 WO2023034265A1 (en) | 2021-08-31 | 2022-08-30 | Methods and compositions for treating sleep apnea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534173A JP2024534173A (ja) | 2024-09-18 |
| JP2024534173A5 true JP2024534173A5 (enExample) | 2025-09-08 |
Family
ID=83448045
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513202A Pending JP2024534173A (ja) | 2021-08-31 | 2022-08-30 | 睡眠時無呼吸を治療するための方法及び組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240358709A1 (enExample) |
| EP (1) | EP4395721A1 (enExample) |
| JP (1) | JP2024534173A (enExample) |
| KR (1) | KR20240053061A (enExample) |
| CN (1) | CN117956959A (enExample) |
| AU (1) | AU2022340532A1 (enExample) |
| CA (1) | CA3230016A1 (enExample) |
| WO (1) | WO2023034265A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024220343A1 (en) * | 2023-04-18 | 2024-10-24 | Apnimed, Inc. (Delaware) | Combination of a norepinephrine reuptake inhibitor and a melatonin receptor agonist for use in treating sleep apnea |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| KR20240042261A (ko) * | 2017-04-28 | 2024-04-01 | 더 브리검 앤드 우먼즈 하스피털, 인크. | 수면 무호흡을 치료하기 위한 방법 및 조성물 |
-
2022
- 2022-08-30 CA CA3230016A patent/CA3230016A1/en active Pending
- 2022-08-30 CN CN202280058855.2A patent/CN117956959A/zh active Pending
- 2022-08-30 WO PCT/US2022/041990 patent/WO2023034265A1/en not_active Ceased
- 2022-08-30 JP JP2024513202A patent/JP2024534173A/ja active Pending
- 2022-08-30 EP EP22777430.4A patent/EP4395721A1/en active Pending
- 2022-08-30 KR KR1020247010354A patent/KR20240053061A/ko active Pending
- 2022-08-30 AU AU2022340532A patent/AU2022340532A1/en active Pending
- 2022-08-30 US US18/687,660 patent/US20240358709A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023139000A5 (enExample) | ||
| ES3004544T3 (en) | Film formulations containing dexmedetomidine and methods of producing them | |
| ES2393211T3 (es) | Uso de 2-aminotetralinas sustituidas para la fabricación de un medicamento para la prevención, alivio y/o tratamiento de diversos tipos de dolor | |
| JP2015512406A5 (enExample) | ||
| JP2009536176A5 (enExample) | ||
| JP2023181322A (ja) | 睡眠時無呼吸を治療するための方法および組成物 | |
| HRP20160189T1 (hr) | Liječenje crohnove bolesti lakvinimodom | |
| JP2020517719A5 (enExample) | ||
| JP2009541443A5 (enExample) | ||
| JP2017528507A5 (enExample) | ||
| JP2005512995A5 (enExample) | ||
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| JP2005533860A5 (enExample) | ||
| AU2011231645A2 (en) | Fast dissolving drug delivery systems | |
| CU23468B7 (es) | Forma de dosificación de pramipexol en una dosis única diaria | |
| TW200808295A (en) | Use of agomelatine in obtaining medicaments intended for the treatment of generalized anxiety disorder | |
| RU2018136580A (ru) | Цитратная соль (s)-4-((s)-3-фтор-3-(2-(5,6,7,8-тетрагидро-1,8-нафтиридин-2-ил)этил)пирролидин-1-ил)-3-(3-(2-метоксиэтокси)фенил)бутановой кислоты | |
| JP2013507442A5 (enExample) | ||
| JP2009504774A5 (enExample) | ||
| JP2013536837A5 (enExample) | ||
| RU2007119067A (ru) | Средство для лечения синдрома раздраженного кишечника с преобладанием диареи | |
| JP2024511091A5 (enExample) | ||
| JP2008509147A5 (enExample) | ||
| JP2024523876A5 (enExample) | ||
| JP2009545593A5 (enExample) |